FDAsafety guidance72% confidence
Master Protocols for Drug and Biological Product Development
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as competitors in post-surgical pain solutions.
Regulatory Analysis
Supporting Context
- Therapeutic area
- Obstetrics · Chronic Pain Management
- Sub-indication
- Pain
Related signal: Study on Chronic Post-Cesarean Pain Under ERAS Protocol